Thank you to our partners at Nasdaq for featuring bioAffinity Technologies in its Amplify Spotlight interview series. Host Michael Spector spoke to our President/CEO Maria Zannes. Watch the video at https://bit.ly/4a7VJDq #BIAF #Nasdaq #biotech #lungcancer #CyPathLung #lungcancerscreening #earlydiagnosis
bioAffinity Technologies
Biotechnology
San Antonio, Texas 932 followers
Addressing a critical need to find cancer early and treat cancer at the cellular level.
About us
bioAffinity Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage lung cancer and other diseases of the lung. The Company’s first product, CyPath® Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath® Lung is especially useful for patients whose lung cancer screening or other scan reveals a pulmonary nodule. Our first product, CyPath® Flow Cytometry for Lung Cancer (CyPath® Lung), has been licensed by Precision Pathology Services for continued development and commercial sale as a Laboratory Developed Test. CyPath® Lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.
- Website
-
https://www.bioaffinitytech.com/
External link for bioAffinity Technologies
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- San Antonio, Texas
- Type
- Public Company
- Founded
- 2014
Locations
-
Primary
22211 W Interstate 10
San Antonio, Texas 78257, US
Employees at bioAffinity Technologies
-
Jacqulyn Kennedy
bioAffinity ~ CyPath Lung ~ Disruptive Technology ~ Multiple P-Club Winner ~ Top Performer ~ Over Achiever Highly Driven & Results Orientated Real…
-
Bill Bauta
Chief Science Officer at bioAffinity Technologies
-
Stuart Diamond
Chief Financial Officer at GroupM -- WPP Company
-
Jamie Platt
Transformational Genomics Executive – Driving Value and Growth from Research to Revenue.
Updates
-
CyPath Lung patient Steve T talks about the importance of lung cancer screening and how he discovered CyPath Lung as a great adjunct to low dose CT. #LDCT #CyPathLung #lungcancer #screeningsaveslives #LungNodules
-
In this video, Tarun Madappa, MD, tells us why he has incorporated CyPath Lung into his practice to help assess patients at high risk for lung cancer. Dr Madappa practices Pulmonary Disease & Critical Care Medicine at CHRISTUS Spohn Hospital in Corpus Christi, TX. #CyPathLung #pulmonology #lungcancerdetection #screeningsaveslives #lungcancer
-
You can still register for today's RedChip webinar with bioAffinity Technologies President and CEO Maria Zannes. Register at https://bit.ly/3BvDV8m for the webinar at 4:15 pm ET. RedChip provides investor relations, financial media, and research services for microcap and small-cap stocks. #BIAF #microcapstocks #smallcaps #CyPathLung #lungcancer #investing #lungcancderdiagnostics
-
Join us at the RedChip Investor Webinar with bioAffinity Technologies (NASDAQ: BIAF) on Thursday, Dec. 19, 2024, at 4:15 PM ET. Register at https://bit.ly/3BvDV8m RedChip provides investor relations, financial media, and research services for microcap and small-cap stocks. #BIAF #microcapstocks #smallcaps #CyPathLung #lungcancer #investing #lungcancderdiagnostics
-
Dr. Chris T. Pernell, MD, MPH, FACPM, center, Director of the NAACP Center for Health Equity, delivered a dynamic keynote address to more than 400 physicians, healthcare professionals and patient advocates at the 2024 ACS National Lung Cancer Roundtable in Atlanta this week. bioAffinity CEO Maria Zannes, left, and Lisa Bland Malone, NAACP Director of Policy and Legislative Affairs, are pictured here with Dr. Pernell. Dr. Pernell is a dynamic physician leader and social change agent. In her practice, she focuses on health justice, community-based advocacy, and population-wide health promotion and disease prevention. #ASC #lungcancer #CyPathLung #NAACP
-
Thank you to our partners at the National Association of Veterans' Research and Education Foundations for highlighting our successful campaign to add CyPath Lung to the VA's medical supply chain and the professional staff at the VA who made it happen. See our press release at https://bit.ly/3B43bm5 #navref #CyPathLung #lungcancer #veteranshealth #BIAF